Alcoholic liver disease (ALD) is one of the most common etiologies of liver disease and has become a main cause of morbidity and mortality worldwide (Lachenmeier et al. 2014; Ramaiah et al. 2004 ). ALD encompasses a broad spectrum of disorders (,) ranging from fatty liver to more severe forms of liver injury, including alcoholic hepatitis, fibrosis, cirrhosis, and superimposed hepatocellular carcinoma (Gao and Bataller 2011; Orman et al. 2013) . Alcoholic liver fibrosis (ALF) is identified as a breaking point in ALD because it can lead to cirrhosis (Duddempudi 2012) . Therefore, the research on the molecular pathways and therapeutic strategies for ALF has attracted considerable attention in scholarly circles.
Although the development of ALF is complicated involving different molecular and biological mechanisms, mounting evidence suggests that the principal metabolite of ethanol, acetaldehyde, plays a critical role in the onset and maintenance of the fibrogenetic process. Many studies have demonstrated that acetaldehyde stimulates the deposition of extracellular matrix (ECM) by activating the hepatic stellate cells D r a f t immunity in ALD (Gao et al. 2011) . In addition, the spleen is also thought to be central in regulating the immune system with regard to non-alcoholic fatty liver disease (NAFLD), and previous research has shown that splenomegaly was secondary to portal hypertension with associated liver cirrhosis (Tarantino 2011). Gualde and Harizi have previously reported that splenic macrophages, dendritic cells, and lymphocytes contribute to prostaglandin E2 (PGE2) synthesis in the spleen (Gualde and Harizi 2004) . Katia et al. have also found that PGE2 regulate Th17 cell differentiation and function through cAMP and EP2/EP4 receptor signaling (Boniface et al. 2009 ). These results further suggest that a better understanding of the cAMP axis is likely to provide new insights into the regulation of innate immunity, which would provide therapeutic benefit for ALD.
Most of the effects of cAMP are dependent upon the activation of its downstream effectors protein kinase A (PKA). In our previous study, we found that the activation of cAMP/PKA signaling pathway promotes the activation and proliferation of HSCs (Wang et al. 2014; Wang et al. 2015; Yang et al. 2015) . cAMP acts via three mechanisms: PKA, Exchange protein activated by cAMP (EPAC) and cyclic nucleotide-gated (CNG) ion channels (Insel et al. 2012; Roberts and Dart 2014) .
Interestingly, it has recently been shown that EPAC mediate the antifibrotic effect of cAMP (Yokoyama et al. 2008b ). EPAC proteins regulate many cellular processes, including migration, proliferation and apoptosis, via a PKA-independent pathway (Okumura et al. 2014; Yokoyama et al. 2008a) . There are two main EPAC isoforms (EPAC1 and EPAC2, also known as RapGEF3 and RapGEF4, respectively) that are expressed from different genes in a variety of tissues (de Rooij et al. 1998; Roscioni et al. 2008; Ueno et al. 2001) . EPAC proteins respond to cAMP and act as specific guanine nucleotide exchange factors (GEFs) for the small G proteins, Rap1 and Rap2 which were activated by exchanging bound GDP for GTP, while GTPase activating proteins return them to inactive GDP-bound states (Breckler et al. 2011; de Rooij et al. 1998; Jeyaraj et al. 2011; Schmidt et al. 2013) . Based on these findings, we hypothesized that cAMP may influence acetaldehyde-induced HSCs activation by regulating the activation of both PKA and EPAC signaling pathways.
In this study, the rat HSC line were cultured and treated with 200 µM acetaldehyde for 48 h, which was proposed to mimic the activation process in vivo.
We then tried to identify the role of cAMP/EPAC/Rap1 signaling pathway in the regulation of HSCs activation and proliferation induced by acetaldehyde. 
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Materials and methods
Antibodies and reagents
Cell cycle analysis
To analyze the intracellular DNA content of HSCs which transfected EPAC siRNA, Cell Cycle Analysis Kit was used (Beyotime, China) according to the manufacturer's instruction. HSCs were fixed in 70% ethanol at -20 ℃ overnight. Then cells were centrifuged at 3000 rpm for 5 min and re-suspended in Phosphate Buffered Saline (PBS). After then, HSCs were stained with 0.5ml of propidium iodide (PI) staining buffer, including 200 mg/ml RNase A, 50 µg/ml PI, at 37 ℃ for 30 min in the dark. Analyses were performed on Cytomics FC500 MCL (Beckman coulter, USA).
Western blot analysis
Cells were washed with PBS thrice and lysed with RIPA (Beyotime, China)
buffer containing protease inhibitor phenylmethylsulfonyl-fluoride (PMSF; Biosharp, USA). Protein concentrations was determined by the BCA protein assay kit (Boster, China). After separating by sodium dodecylsulfate polyacrylamide gel electrophoresis (10%; 80 V for 30 min and then 120 V for 90 min), the proteins were transferred onto a PVDF membrane (Millipore, USA). The blots were incubated overnight at 4 °C with primary antibodies diluted with TBS/Tween-20 (0.075%) containing 3% Marvel after blocking for 3 h. The antibody of collagen type I, collagen type III, α-SMA were diluted to 1:1000; EPAC1, EPAC2, Rap1GAP, Rap1 and β-actin were diluted to 1:500. Membranes were then washed with TBS/Tween-20 thrice, incubated with secondary antibodies (1:10000 diluted) for 1 h at room temperature. Finally repeating the washing again, protein bands was detected with enhanced chemiluminescence reagent (ECL; Thermo Scientific, USA). All experiments were performed at least three times with three independent protein extracts.
Quantitative real-time PCR analysis (QRT-PCR)
Total RNA was extracted from HSCs using TRIzol reagent. The first-strand cDNA was generated from total RNA using AMV Reverse Transcriptase 
Rap1 Activation Assay
The activation of Rap1 was examined by a Rap1 Activation Assay Kit µL/well of pull-down supernatant were loaded onto a 12% polyacrylamide gel and further analyzed with western blot using Rap1 specific antibody.
RNA interference
Small interfering RNA (siRNA) oligonucleotides against EPAC1, EPAC2 genes and negative control sequences were designed and synthesized by the Shanghai Gena Pharma (Shanghai, China) and contained the following sequences: EPAC1 siRNA forward: 5'-CCA GCA UUC UGAUCU ACA UTT -3' and reverse: 5'-AUG UAG D r a f t
All results are presented as the mean ± SD. Differences between 2 groups were analyzed by 2-tailed Student's t test, differences among > 2 groups were analyzed by one-way ANOVA. P < 0.05 was considered statistically significant.
Results
Quantification of the expression of EPAC1 and EPAC2 in acetaldehyde-induced HSCs
To investigate whether the expression of EPAC1 and EPAC2 were altered in acetaldehyde-induced HSCs, the QRT-PCR and western blotting were applied to quantify the levels of the mRNA and protein for EPAC1 and EPAC2. The HSCs were treated with 200 µM acetaldehyde for 48 h. Our results showed that the expression of EPAC2 at both protein and mRNA levels were significantly increased as compared with that of control group, whereas the expression of EPAC1 was decreased markedly by the addition of acetaldehyde (Fig. 1) .
Effect of EPAC on proliferation and activation of acetaldehyde-induced HSCs
The HSCs were pretreated with acetaldehyde (200 µM) for 24 h, and co-cultured with Me-cAMP (50 µM) for 24 h. As shown in Fig. 2a , Me-cAMP restored the expression of EPAC1, and the expression EPAC2 was slightly increased. MTT assay showed that Me-cAMP displayed remarkable inhibition of the proliferation in acetaldehyde-induced HSCs (Fig. 3a) . As shown in Fig. 3b , the results of cell cycle analysis showed that Me -cAMP increased the ratio of cells in the G0/G1 phase and decreased those in the S and G2/M phase. There were significant differences in the ratio of cells in G0/G1 phase and S plus G2/M phase between Me-cAMP-treated groups and model group. Furthermore, addition of Me-cAMP potently decreased the mRNA and protein expression of α-SMA, collagen type I and III in acetaldehyde-induced HSCs (Fig. 2b) .
To gain insight into the potential signaling pathways mediated by EPAC, the protein levels of both Rap1-GTP and total Rap1 were determined. As shown in Fig.   3c , the expression of Rap1-GTP were significantly downregulated by acetaldehyde but upregulated by Me-cAMP, whereas total Rap1 protein levels remained unchanged, indicating that EPAC activation by Me-cAMP enhanced the expression of GTP-bound (activated) Rap1.
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Effect of EPAC siRNA on proliferation and activation of acetaldehyde-induced
HSCs
To further dissect the functional role of EPAC1 and EPAC2, the small interfering RNA was used. After 48 h following the transfection, the cells were photographed at ×920 magnification by fluorescence microscope (data not shown).
Transfection efficiency detected by western blot (Fig. 4) and QRT-PCR (data of QRT-PCR was not shown). As shown in Fig. 5a , EPAC2 siRNA significantly inhibited the proliferation of HSCs, whereas EPAC1 siRNA and double knockdown of EPAC1 and 2 remarkably increased the rate of HSC proliferation. In accordance with the findings from previous studies, the results of cell cycle analysis showed that only EPAC2 siRNA enhanced the ratio of cells in the G0/G1 phase and decreased those in the S and G2/M phase apparently (Fig. 5b ). In addition, double knockdown of EPAC1 and 2 had a profound promotion of the expression of α-SMA and collagen type I and type III (Fig. 6 ).
QRT-PCR and western blot results indicated that knockdown of EPAC1 further
enhanced acetaldehyde-induced α-SMA and collagen type I and III mRNA and protein levels (Fig. 7a) . However, EPAC2 depletion prevented the increase of both collagen type I and III, and inhibited acetaldehyde-induced α-SMA expression strongly (Fig. 7b) . Taken together, these data suggested that the activation and proliferation of HSCs could be suppressed by EPAC1 and promoted by EPAC2.
EPAC and PKA activation had opposite effects on synthesis of collagen and
α-SMA in acetaldehyde-induced HSCs D r a f t activation by Phe-cAMP had negligible effects on such binding (Fig. 8b) . These data further demonstrated that EPAC could play a protective role against acetaldehyde-induced HSCs activation via Rap1. Experiments have shown that the cyclooxygenase-2 (COX-2)/PGE2 signaling mechanism was involved in mediating proliferation of HSC, and COX-2 specific inhibitors could attenuate hepatic fibrosis probably via COX-2/PGE2/cAMP pathway (Hui et al. 2004; Zhao et al. 2012) . Previous studies have also revealed the remarkably enhanced expression of COX-2 in experimental ALD (Nanji et al. 1997) . In our prior studies, we found that activated HSCs isolated from alcohol induced fibrotic rat liver displayed a dramatic upregulation of the cAMP/PKA/CREB signaling pathway, which was positively correlated with the progression of liver fibrosis , indicating that the COX-2/PGE2/cAMP pathways may have major effects on the activation of HSCs induced by acetaldehyde.
Discussion
The effects of cAMP are mediated by two ubiquitously expressed cAMP receptors: the classical PKA and the recently discovered EPAC. EPAC1 and EPAC2
are multidomain proteins, the biggest structural difference between EPAC1 and EPAC2 is the existence of an additional cyclic nucleotide-binding domain (CNBD) within the N terminus of EPAC2 (Banerjee and Cheng 2015; Kawasaki et al. 1998 ).
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The extra part exhibits a reduced affinity for cAMP and is incapable to induce GEF activity following cAMP binding. EPAC1 and EPAC2 share high structural homology throughout their regulatory and catalytic domains despite this difference (Parnell et al. 2015; Rehmann et al. 2008) . In our article, QRT-PCR and western blot were used to quantify both protein and mRNA levels of the two isoforms of EPAC. Our results showed that both two isoforms could be present in rat HSCs. Furthermore, the expression of EPAC2 was significantly increased in acetaldehyde-induced HSCs as compared with that of control group, whereas the expression of EPAC1 was down-regulated by the addition of acetaldehyde. These results suggested that perhaps EPAC1 or EPAC2 may in part responsible for regulating HSCs activation, such as the production of α-SMA and collagen type I and III.
According to the previous results, the analog of natural cAMP, Me-cAMP, was used. It is more than tenfold as efficient as cAMP in activating EPAC1 in vitro, and results in a threefold-higher maximum activity of EPAC1, causing this analog a so-called superagonist for EPAC1 (Rehmann et al. 2003) . Whereas EPAC activation not only apparently reduced the expression of α-SMA, collagen type I and III production as compared with the model group, but also suppressed the proliferation of HSCs. Hence we speculate that the reduction caused by activation of EPAC, perhaps by EPAC1 to a large extent, though acetaldehyde induced enhancive expression of EPAC2. In other words, blunt the decrease in EPAC expression, especially EPAC1, may thus be strategies to block or reverse alcoholic liver fibrosis.
To gain insight into the pathways mediated by EPAC, the protein levels of both Rap1-GDP and total Rap1 were determined. EPAC have been viewed as a family of D r a f t cAMP-responsive GEFs for Rap1 (Li et al. 2015) . Data from our recent study showed that Me-cAMP upregulated it while total Rap1 proteins remained unchanged.
To elucidate the mechanism of the impact of EPAC, we silenced EPAC1 or EPAC2 and found that EPAC1 silencing, but not EPAC2, increased acetaldehyde-induced expression of α-SMA, collagen type I and III and the proliferation of HSCs, which is consistent with the observation of Miguel et al.
( Perez-Aso et al. 2013) . Paradoxically, knockdown of both EPAC1 and EPAC2 to the acetaldehyde-induced HSCs showed the same effect as knockdown of EPAC1. Up to now, it is reported that EPAC1 overexpression can lead to cardiac hypertrophy whereas EPAC2 activation can be arrhythmogenic, in part because of distinct subcellular localization, and EPAC1 is localized and functionally involved in nuclear signaling, however EPAC2 is located at the T tubules and regulates arrhythmogenic sarcoplasmic reticulum Ca leak (Pereira et al. 2015) . But why EPAC1 and EPAC2
contribute to differential functional effects in the activation of HSCs is not clealy defined.
In 2014, the scientists observed that Leishmania facilitates an immunosuppressive environment in macrophages by COX2/PGE2/EP2/cAMP signaling that is differentially regulated by PKA and EPAC (Saha et al. 2014) . Results from these studies provided a novel insight into mechanisms by which EPAC and PKA may have independent, or even opposing effects on acetaldehyde-induced D r a f t
In conclusion, in this study we used acetaldehyde-induced HSCs culture as the alcoholic liver fibrosis model to investigate the role of EPAC. The current data showed that both EPAC1 and EPAC2 were present in rat HSCs, and EPAC1 probably exerted more protective influence via Rap1; increasing EPAC activity by Me-cAMP could inhibit profibrotic response and EPAC2 depletion, but not EPAC1, prevented proliferation of HSCs and acetaldehyde-induced increase in α-SMA and collagen type I and III. Moreover, PKA and EPAC activation perhaps had opposite effects on synthesis of collagen in acetaldehyde-induced HSCs and PKA activation had negligible effects on the binding between Rap1 and GTP. This study provided a new insight into the role of EPAC in the pathogenesis of alcohol-induced liver fibrosis and will help to develop a rational use of EPAC agonist-based therapy. c Rap1 activation (GTP-bound) was probed by western blot.
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